Tumor regression concomitant with steroid-refractory GvHD highlights the pitfalls of PD-1 blockade following allogeneic hematopoietic stem cell transplantation

Bone Marrow Transplant. 2017 May;52(5):759-761. doi: 10.1038/bmt.2016.346. Epub 2017 Jan 9.
No abstract available

Publication types

  • Case Reports
  • Research Support, N.I.H., Intramural

MeSH terms

  • Allografts
  • Antibodies, Monoclonal / administration & dosage*
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Female
  • Graft vs Host Disease / pathology
  • Graft vs Host Disease / therapy*
  • Hematopoietic Stem Cell Transplantation*
  • Hodgkin Disease
  • Humans
  • Nivolumab
  • Programmed Cell Death 1 Receptor / antagonists & inhibitors*
  • Steroids / administration & dosage*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor
  • Steroids
  • Nivolumab
  • pembrolizumab